Caris Life Sciences/$CAI
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Caris Life Sciences
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Ticker
$CAI
Sector
Primary listing
Employees
1,769
Headquarters
Website
CAI Metrics
BasicAdvanced
$7.7B
-
-$6.48
-
-
Price and volume
Market cap
$7.7B
52-week high
$42.50
52-week low
$22.86
Average daily volume
2.4M
Financial strength
Current ratio
9.93
Quick ratio
9.11
Long term debt to equity
87.836
Total debt to equity
89.208
Interest coverage (TTM)
-1.37%
Profitability
EBITDA (TTM)
-52.954
Gross margin (TTM)
60.18%
Net profit margin (TTM)
-28.81%
Operating margin (TTM)
-12.38%
Revenue per employee (TTM)
$370,000
Management effectiveness
Valuation
Price to revenue (TTM)
4.409
Price to book
16.03
Price to tangible book (TTM)
16.71
Price to free cash flow (TTM)
-204.324
Free cash flow yield (TTM)
-0.49%
Free cash flow per share (TTM)
-0.133
Growth
What the Analysts think about CAI
Analyst ratings (Buy, Hold, Sell) for Caris Life Sciences stock.
CAI Financial Performance
Revenues and expenses
CAI Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Caris Life Sciences stock?
Caris Life Sciences (CAI) has a market cap of $7.7B as of December 18, 2025.
What is the P/E ratio for Caris Life Sciences stock?
The price to earnings (P/E) ratio for Caris Life Sciences (CAI) stock is 0 as of December 18, 2025.
Does Caris Life Sciences stock pay dividends?
No, Caris Life Sciences (CAI) stock does not pay dividends to its shareholders as of December 18, 2025.
When is the next Caris Life Sciences dividend payment date?
Caris Life Sciences (CAI) stock does not pay dividends to its shareholders.
What is the beta indicator for Caris Life Sciences?
Caris Life Sciences (CAI) does not currently have a Beta indicator.